Skip to main content
Clinical Trials/NL-OMON33946
NL-OMON33946
Completed
Not Applicable

Cross-sectional cohort study to analyse the relation between advanced glycation end-products (AGEs) and diastolic function in patients with diabetes mellitus with and without chronic heart failure. - DIABAGES

niversitair Medisch Centrum Groningen0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diastolic heart failure
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
200
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Signed Informed consent
  • Age \> 18 years;Diabetes patients with chronic heart failure
  • Type 2 DM according to ADA criteria
  • Stable CHF diagnosed according to ESC criteria
  • Duration of HF \> 3 months
  • NYHA functional class II\-IV ;Diabetes patients without chronic heart failure
  • Type 2 DM according to ADA criteria
  • No evidence of heart failure;Patients with chronic heart failure without DM type 2
  • No type 2 DM (fasting glucose \<6\.9 mmol/l)
  • Stable CHF diagnosed according to ESC criteria

Exclusion Criteria

  • Sustained/Accepted atrial fibrillation
  • Severe Valvular Disease
  • Pacemaker use (ICD allowed with backup pacing \<\= 40 bpm)
  • Fitzpatrick type VI skin colour

Outcomes

Primary Outcomes

Not specified

Similar Trials